FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic Dermatitis

2023-04-13T09:47:18-05:00April 14th, 2023|Categories: News Release, Veterinary Pharmacy - Small Animals|Tags: |

While Atopica has been approved for dermatitis in dogs and cats for many years, a generic modified cyclosporine oral solution, Modulis (Provetica, LLC) has now been approved for cats by the U.S. Food and Drug Administration. A generic equivalent to Atopica for dogs, Cyclavance, was approved in October 2020. It is important to [...]

Comments Off on FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic Dermatitis

GFI #256: The Ever-Changing Guidance Town Hall – May 18, 2023

2023-06-07T12:07:59-05:00April 13th, 2023|Categories: Compounding, News Release, Pharmacy Law, Regulatory Issues|Tags: |

On Thursday, May 18, 2023, ACVP presented a virtual Town Hall meeting on GFI #256, who it affects, and how to comply. After a short PowerPoint presentation by Brenda Jensen, CPhT, CNMT, MBA, Gigi Davidson, BSPharm, DICVP, FACVP, FSVHP, moderated a panel discussion on the topic. Panelists: Brian Bowers, PharmD, FACVP Natalie Young, [...]

Comments Off on GFI #256: The Ever-Changing Guidance Town Hall – May 18, 2023
Go to Top